47th week of 2017 patent applcation highlights part 24 |
Patent application number | Title | Published |
20170334848 | PROCESS FOR PREPARING (3RS)-3-[(2SR)-(2-CYCLOPENTYL-2-HYDROXY-2-PHENYLACETYL)OXY]-1,1-DIMETHYLP- YRROLIDINIUM BROMIDE | 2017-11-23 |
20170334849 | ORGANIC COMPOUND AND ELECTRONIC DEVICE COMPRISING AN ORGANIC LAYER COMPRISING THE ORGANIC COMPOUND | 2017-11-23 |
20170334850 | CRYSTALLINE COMPOUNDS | 2017-11-23 |
20170334851 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | 2017-11-23 |
20170334852 | CATIONIC LIPID | 2017-11-23 |
20170334853 | MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS AND USES THEREOF | 2017-11-23 |
20170334854 | One-Step Process For The Synthesis Of Alkylated Metyrapone Analogs | 2017-11-23 |
20170334855 | KCNQ2-5 CHANNEL ACTIVATOR | 2017-11-23 |
20170334856 | PREPARATION METHOD OF 4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPYRIDINE-2-FORMAMIDE | 2017-11-23 |
20170334857 | Method of Purifying and using 4-chloro-n-methy1-2-pyridinecarboxamide | 2017-11-23 |
20170334858 | PROCESS FOR THE PREPARATION OF INTERMEDIATE OF DOLUTEGRAVIR | 2017-11-23 |
20170334859 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | 2017-11-23 |
20170334860 | NOVEL POLYMORPHS OF IVACAFTOR, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THEREOF | 2017-11-23 |
20170334861 | TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF | 2017-11-23 |
20170334862 | IMIDAZOLE DERIVATIVES AS PRODRUGS OF DICLOFENAC | 2017-11-23 |
20170334863 | Cdc42 INHIBITOR AND USES THEREOF | 2017-11-23 |
20170334864 | 3,5-DIAMINO-6-CHLORO-N-(N-(4-(4-(2-(HEXYL(2,3,4,5,6-PENTAHYDROXYHEXYL)AMIN- O)ETHOXY)PHENYL)BUTYL) CARBAMIMIDOYL)PYRAZINE-2-CARBOXAMIDE | 2017-11-23 |
20170334865 | DDR2 INHIBITORS AND METHODS OF USING | 2017-11-23 |
20170334866 | CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS | 2017-11-23 |
20170334867 | PROTEASE INHIBITORS | 2017-11-23 |
20170334868 | COMPOSITIONS AND METHODS OF TREATMENT WITH PRODRUGS OF TIZOXANIDE, AN ANALOGUE OR SALT THEREOF | 2017-11-23 |
20170334869 | NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER | 2017-11-23 |
20170334870 | PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE | 2017-11-23 |
20170334871 | Thymoquinone Derivatives for Treatment of Cancer | 2017-11-23 |
20170334872 | SEMI-SYNTHESIS PROCEDURES | 2017-11-23 |
20170334873 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | 2017-11-23 |
20170334874 | PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME | 2017-11-23 |
20170334875 | METHOD FOR THE PRODUCTION OF VITAMIN E WITH A HIGH PURITY, VITAMIN E PRODUCED BY SAID METHOD, AND A COMPOSITION COMPRISING SAID VITAMIN E | 2017-11-23 |
20170334876 | NOVEL CYCLIC COMPOUND AND OPTICAL MATERIAL COMPOSITION INCLUDING SAME | 2017-11-23 |
20170334877 | REVAPRAZAN HYDROCHLORIDE POLYMORPHS AND PREPARATION METHOD THEREFOR | 2017-11-23 |
20170334878 | SYNTHESIS OF 6-ARYL-4-AMINOPICOLINATES AND 2-ARYL-6-AMINOPYRIMIDINE-4-CARBOXYLATES BY DIRECT SUZUKI COUPLING | 2017-11-23 |
20170334879 | HISTONE DEMETHYLASE INHIBITORS | 2017-11-23 |
20170334880 | PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF BACTERIAL DISEASES | 2017-11-23 |
20170334881 | NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES | 2017-11-23 |
20170334882 | HEPATITIS B ANTIVIRAL AGENTS | 2017-11-23 |
20170334883 | THERAPEUTIC COMPOUNDS AND USES THEREOF | 2017-11-23 |
20170334884 | PROCESS FOR THE PURIFICATION OF THE AXL TYROSINE RECEPTOR KINASE INHIBITOR "R428" | 2017-11-23 |
20170334885 | PYRAZOLE COMPOUNDS | 2017-11-23 |
20170334886 | N-SUBSTITUTED 4-AMINOQUINAZOLINE DERIVATIVES AND METHODS OF USE | 2017-11-23 |
20170334887 | Imidazole-Based Antimicrobial Agents | 2017-11-23 |
20170334888 | SYNTHESIS OF UDP-GLUCOSE: N-ACYLSPHINGOSINE GLUCOSYLTRANSFERASE INHIBITORS | 2017-11-23 |
20170334889 | COMPOUNDS AND METHODS FOR ACTIVATING THE APOPTOTIC ARM OF THE UNFOLDED PROTEIN RESPONSE | 2017-11-23 |
20170334890 | SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION | 2017-11-23 |
20170334891 | ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS | 2017-11-23 |
20170334892 | LKB1-AMPK ACTIVATORS FOR THERAPEUTIC USE IN POLYCYSTIC KIDNEY DISEASE | 2017-11-23 |
20170334893 | Isoxazole Analogs as FXR Agonists and Methods of Use Thereof | 2017-11-23 |
20170334894 | Isoxazole Derivatives as FXR Agonists and Methods of Use Thereof | 2017-11-23 |
20170334895 | DOPAMINE D3 RECEPTOR ANTAGONIST COMPOUNDS | 2017-11-23 |
20170334896 | Substituted Heterocyclic Derivative, Preparation Method And Use Thereof | 2017-11-23 |
20170334897 | Liver X Receptor (LXR) Modulators For The Treatment Of Dermal Diseases, Disorders And Conditions | 2017-11-23 |
20170334898 | NOVEL 4-METHYL-DIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | 2017-11-23 |
20170334899 | AMINO-SUBSTITUTED ISOTHIAZOLES | 2017-11-23 |
20170334900 | NEW PYRAZOLE DERIVATIVES AS NIK INHIBITORS | 2017-11-23 |
20170334901 | QUINOLINONE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS | 2017-11-23 |
20170334902 | BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | 2017-11-23 |
20170334903 | METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | 2017-11-23 |
20170334904 | PYRIMIDO[4,5-B]INDOLE DERIVATIVES AND USE THEREOF IN THE EXPANSION OF HEMATOPOIETIC STEM CELLS | 2017-11-23 |
20170334905 | NOVEL COMPOSITIONS, USES AND METHODS FOR MAKING THEM | 2017-11-23 |
20170334906 | NEW COMPOUNDS AS NIK INHIBITORS | 2017-11-23 |
20170334907 | BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | 2017-11-23 |
20170334908 | NOVEL HIGH PENETRATION DRUGS AND THEIR COMPOSITIONS THEREOF FOR TREATMENT OF PARKINSON DISEASES | 2017-11-23 |
20170334909 | SYNTHESIS OF A COMPOUND THAT MODULATES KINASES | 2017-11-23 |
20170334910 | FORMS OF METHYL {4,6-DIAMINO-2-[1 (2-FLUOROBENZYL)-1H-PYRAZOLO[3-4-B]PYRIDINO-3-YL]PYRIMIDINO-5-YL}METHYL CARBAMATE | 2017-11-23 |
20170334911 | N-SUBSTITUTED BETA-CARBOLINIUM COMPOUNDS AS POTENT P-GLYCOPROTEIN INDUCERS | 2017-11-23 |
20170334912 | Purine Diones As Wnt Pathway Modulators | 2017-11-23 |
20170334913 | Methods Of Preparing Carbocyclic Nucleosides | 2017-11-23 |
20170334914 | DUAL SELECTIVE PI3 DELTA AND GAMMA KINASE INHIBITORS | 2017-11-23 |
20170334915 | NEW PYRAZOLOPYRIMIDINE DERIVATIVES AS NIK INHIBITORS | 2017-11-23 |
20170334916 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | 2017-11-23 |
20170334917 | PIPERIDINYLPYRAZOLOPYRIMIDINONES AND THEIR USE | 2017-11-23 |
20170334918 | BMP Inhibitors and Methods of Use Thereof | 2017-11-23 |
20170334919 | 2-((4-AMINO-3-(3-FLUORO-5-HYDROXYPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1 -YL)METHYL)-3-(2-(TRIFLUORO-MET HYL)BENZYL)QUINAZOLIN-4(3H)-ONE DERIVATIVES AND THEIR USE AS PHOSPHOINOSITIDE 3-KINASE INHIBITORS | 2017-11-23 |
20170334920 | FUSED HETEROARYL PYRIDYL AND PHENYL BENZENESUFLONAMIDES AS CCR2 MODULATORS FOR THE TREATMENT OF INFLAMMATION | 2017-11-23 |
20170334921 | CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR | 2017-11-23 |
20170334922 | SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF | 2017-11-23 |
20170334924 | Spirocyclic Heterocyclic Compounds Useful As HIV Integrase Inhibitors | 2017-11-23 |
20170334925 | Thienopyranones as Kinase and Epigenetic Inhibitors | 2017-11-23 |
20170334926 | PROCESS FOR PREPARING SUBSTITUTED INDOLE COMPOUNDS | 2017-11-23 |
20170334927 | Nitroimidazole Compound, Preparation Method Therefor And Use Thereof In Drug Manufacturing | 2017-11-23 |
20170334928 | Purification of Rapamycin Derivatives Using Temperature Induced Phase Separation | 2017-11-23 |
20170334929 | DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES | 2017-11-23 |
20170334930 | BACE1 INHIBITORS | 2017-11-23 |
20170334931 | 2,3-Dihydro-Thiazolo[3,2-A]Pyridin-5-One Derivatives, Intermediates Thereof, and Their Use as Antibacterial Agents | 2017-11-23 |
20170334932 | CHIMERIC COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF | 2017-11-23 |
20170334933 | SURFACE TREATMENT AGENT AND NOVEL COMPOUND | 2017-11-23 |
20170334934 | Macrocyclic picolinamides as fungicides | 2017-11-23 |
20170334935 | PROCESS FOR PURIFYING MONOOCTYLIN TRICHLORIDE | 2017-11-23 |
20170334936 | ANTHRACENE-9, 10-DIONE DIOXIME COMPOUND PRODRUGS AND THEIR USES | 2017-11-23 |
20170334937 | PYRIMIDINE PHOSPHONIC ACID ESTERS | 2017-11-23 |
20170334938 | ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY | 2017-11-23 |
20170334939 | MODULAR ASSEMBLY OF METAL-ORGANIC SUPER-CONTAINERS INCORPORATING CALIXARENES | 2017-11-23 |
20170334940 | NOVEL GALACTOSIDE INHIBITOR OF GALECTINS | 2017-11-23 |
20170334941 | 2',2'-DIHALO NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER | 2017-11-23 |
20170334942 | DERIVATIVES OF URIDINE 5'-CYCLOPHOSPHATE USEFUL TO TREAT HEPATITIS C VIRAL INFECTIONS | 2017-11-23 |
20170334943 | 6-ARYL-9-GLYCOSYLPURINES AND USE THEREOF | 2017-11-23 |
20170334944 | NEUROACTIVE 19-ALKOXY-17(20)-Z-VINYLCYANO-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME | 2017-11-23 |
20170334945 | EXTENDED BETULINIC ACID ANALOGS | 2017-11-23 |
20170334946 | OXOLUPENE DERIVATIVES | 2017-11-23 |
20170334947 | AFFINITY SEPARATION MATRIX FOR FAB REGION-CONTAINING PEPTIDE | 2017-11-23 |
20170334948 | LIGANDS FOR ANTIBODY AND FC-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMOTOGRAPHY IV | 2017-11-23 |